acutus medical inc - AFIB

AFIB

Close Chg Chg %
0.00 -0.00 -97.44%

Closed Market

0.00

0.00 (97.44%)

Volume: 136.84K

Last Updated:

Dec 26, 2025, 2:31 PM EDT

Company Overview: acutus medical inc - AFIB

AFIB Key Data

Open

$0.00

Day Range

0.00 - 0.00

52 Week Range

0.00 - 0.08

Market Cap

$0.00

Shares Outstanding

29.91M

Public Float

24.79M

Beta

-1.31

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.32

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

14.22K

 

AFIB Performance

1 Week
 
0.00%
 
1 Month
 
-90.00%
 
3 Months
 
-88.89%
 
1 Year
 
-99.82%
 
5 Years
 
-100.00%
 

AFIB Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About acutus medical inc - AFIB

Acutus Medical, Inc. is an arrhythmia management company, which engages in improving the way cardiac arrhythmias are diagnosed and treated. Its product portfolio includes novel access sheaths, diagnostic and mapping catheters, conventional and contact ablation catheters, mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The company was founded by Randell L. Werneth and Christoph Scharf on March 25, 2011 and is headquartered in Carlsbad, CA.

AFIB At a Glance

Acutus Medical, Inc.
2210 Faraday Avenue
Carlsbad, California 92008
Phone 1-442-232-6080 Revenue 20.16M
Industry Medical Specialties Net Income -9,547,000.00
Sector Health Technology 2024 Sales Growth 181.365%
Fiscal Year-end 12 / 2025 Employees 85
View SEC Filings

AFIB Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.081
Price to Book Ratio N/A
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -4.697
Enterprise Value to Sales 1.16
Total Debt to Enterprise Value 1.53

AFIB Efficiency

Revenue/Employee 237,141.176
Income Per Employee -112,317.647
Receivables Turnover 2.559
Total Asset Turnover 0.488

AFIB Liquidity

Current Ratio 2.056
Quick Ratio 1.913
Cash Ratio 1.127

AFIB Profitability

Gross Margin 5.026
Operating Margin -29.791
Pretax Margin -22.503
Net Margin -47.363
Return on Assets -10.982
Return on Equity N/A
Return on Total Capital -18.766
Return on Invested Capital -17.709

AFIB Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 147.956
Total Debt to Total Assets 124.839
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 115.017
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Acutus Medical Inc - AFIB

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
17.26M 16.36M 7.16M 20.16M
Sales Growth
+103.96% -5.21% -56.22% +181.37%
Cost of Goods Sold (COGS) incl D&A
32.92M 31.91M 10.30M 19.14M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
6.89M 7.13M 874.00K 1.03M
Depreciation
6.25M 6.71M 874.00K 1.03M
Amortization of Intangibles
- - 640.00K 420.00K
-
COGS Growth
+107.22% -3.08% -67.72% +85.85%
Gross Income
(15.66M) (15.55M) (3.14M) 1.01M
Gross Income Growth
-110.94% +0.73% +79.82% +132.29%
Gross Profit Margin
-90.73% -95.01% -43.79% +5.03%
2021 2022 2023 2024 5-year trend
SG&A Expense
100.21M 75.81M 11.22M 7.02M
Research & Development
- 36.68M 28.15M 3.48M
Other SG&A
63.52M 47.65M 7.74M 7.02M
SGA Growth
+19.56% -24.35% -85.19% -37.47%
Other Operating Expense
- - - -
-
Unusual Expense
(3.75M) 23.36M 3.51M 4.65M
EBIT after Unusual Expense
(112.12M) (114.72M) (17.87M) (10.66M)
Non Operating Income/Expense
116.00K 80.33M 11.67M 11.88M
Non-Operating Interest Income
116.00K 868.00K 2.59M 763.00K
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
5.68M 5.15M 5.66M 5.76M
Interest Expense Growth
+3.11% -9.30% +9.83% +1.82%
Gross Interest Expense
5.68M 5.15M 5.66M 5.76M
Interest Capitalized
- - - -
-
Pretax Income
(117.68M) (39.53M) (11.86M) (4.54M)
Pretax Income Growth
-15.42% +66.41% +70.01% +61.75%
Pretax Margin
-681.71% -241.61% -165.52% -22.50%
Income Tax
- - 82.00K 63.00K
-
Income Tax - Current - Domestic
- - 15.00K 63.00K
-
Income Tax - Current - Foreign
- - - 67.00K
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(117.68M) (39.62M) (11.92M) (4.54M)
Minority Interest Expense
- - - -
-
Net Income
(117.68M) (39.62M) (11.92M) (4.54M)
Net Income Growth
-15.40% +66.34% +69.91% +61.95%
Net Margin Growth
-681.71% -242.11% -166.40% -22.50%
Extraordinaries & Discontinued Operations
- - (69.74M) (5.01M)
-
Discontinued Operations
- - (69.74M) (5.01M)
-
Net Income After Extraordinaries
(117.68M) (39.62M) (81.66M) (9.55M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(117.68M) (39.62M) (81.66M) (9.55M)
EPS (Basic)
-4.107 -1.3987 -2.8067 -0.3207
EPS (Basic) Growth
+54.06% +65.94% -100.66% +88.57%
Basic Shares Outstanding
28.65M 28.32M 29.10M 29.77M
EPS (Diluted)
-4.107 -1.3987 -2.8067 -0.3207
EPS (Diluted) Growth
+54.06% +65.94% -100.66% +88.57%
Diluted Shares Outstanding
28.65M 28.32M 29.10M 29.77M
EBITDA
(108.98M) (84.22M) (13.49M) (4.98M)
EBITDA Growth
-24.79% +22.71% +83.99% +63.09%
EBITDA Margin
-631.28% -514.73% -188.26% -24.70%

Acutus Medical Inc in the News